CVE:IBT IBEX Technologies (IBT) Stock Price, News & Analysis C$1.44 0.00 (0.00%) As of 04/5/2024 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About IBEX Technologies Stock (CVE:IBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBEX Technologies alerts:Sign Up Key Stats Today's RangeC$1.44▼C$1.4450-Day RangeC$1.44▼C$1.4452-Week RangeC$0.75▼C$1.45Volume200 shsAverage Volume68,888 shsMarket CapitalizationC$35.54 millionP/E Ratio11.52Dividend Yield3.11%Price TargetN/AConsensus RatingN/A Company Overview IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada. Read More Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News HeadlinesSupplementary Review: IBEX Limited (IBEX), November 12, 2024November 12, 2024 | msn.comIBEX Announces Record First Quarter of Fiscal Year 2025 Financial ResultsNovember 7, 2024 | markets.businessinsider.comGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.July 22 at 2:00 AM | Paradigm Press (Ad)ibex Launches Wave iX TranslateJuly 23, 2024 | tmcnet.comibex's Christy O'Connor Recognized as Top 10 Corporate Counsel Award WinnerMay 2, 2024 | tmcnet.comIBEX Completes Sale of the CompanyApril 8, 2024 | markets.businessinsider.comIBEX Technologies Inc.: IBEX Shareholders Approve Sale of the CompanyApril 4, 2024 | finanznachrichten.deIBEX Technologies Inc.March 23, 2024 | wsj.comSee More Headlines IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? IBEX Technologies' stock was trading at C$1.44 at the start of the year. Since then, IBT stock has increased by 0.0% and is now trading at C$1.44. How do I buy shares of IBEX Technologies? Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of IBEX Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:IBT CIKN/A Webwww.ibex.ca Phone+1-514-3444004FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.12 Trailing P/E Ratio11.52 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.10 million Net Margins53.78% Pretax MarginN/A Return on Equity21.95% Return on Assets6.42% Debt Debt-to-Equity Ratio11.06 Current Ratio6.24 Quick Ratio4.93 Sales & Book Value Annual SalesC$5.77 million Price / Sales6.15 Cash FlowC$0.92 per share Price / Cash Flow1.56 Book ValueC$0.58 per share Price / Book2.48Miscellaneous Outstanding Shares24,677,792Free FloatN/AMarket CapC$35.54 million OptionableNot Optionable Beta-0.05 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (CVE:IBT) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.